Table 5.

Responses on prioritising ventilator allocation regarding laboratory presentation of COVID-19.

Factor	Low priority (%)	Equal priority (%)	High priority (%)	Mean (SD)	95% CI	Median (IQR)	Skewness
Leukopenia	5 (14.2)	20 (57.2)	10 (28.6)	0.2 (0.7)	0.0, 0.5	0 (0, 1)	−0.3
Lymphopenia	4 (11.4)	16 (45.7)	15 (42.9)	0.3 (0.7)	0.1, 0.6	0 (0, 1)	−0.5
Low platelet count
100 < PLT ≤149	1 (2.9)	27 (77.1)	7 (20.0)	0.2 (0.5)	0.1, 0.4	0 (0, 1)	0.6
50 < PLT ≤99	2 (5.7)	20 (57.2)	13 (37.1)	0.3 (0.6)	0.1, 0.5	0 (0, 1)	−0.2
20 < PLT ≤49	9 (25.7)	15 (42.9)	11 (31.4)	0.1 (0.8)	−0.2, 0.3	0 (−1, 1)	−0.1
PLT <20	11 (31.4)	15 (42.9)	9 (25.7)	−0.1 (0.8)	−0.3, 0.2	0 (−1, 1)	0.1
High LDH	3 (8.6)	21 (60.0)	11 (31.4)	0.3 (0.6)	0.1, 0.5	0 (0, 1)	−0.2
High troponin	6 (17.1)	16 (45.7)	13 (37.2)	0.2 (0.7)	0.0, 0.5	0 (0, 1)	−0.4
High bilirubin
1.2–1.9 mg/dL	4 (11.4)	25 (71.5)	6 (17.1)	0.1 (0.6)	0.0, 0.3	0 (0, 0)	0.0
2.0–5.9 mg/dL	4 (11.4)	22 (62.9)	9 (25.7)	0.1 (0.6)	−0.1, 0.4	0 (0, 1)	−0.1
6.0–11.9 mg/dL	14 (40.0)	13 (37.1)	8 (22.9)	−0.2 (0.8)	−0.5, 0.1	0 (−1, 0)	0.3
≥12.0 mg/dL	16 (45.7)	10 (28.6)	9 (25.7)	−0.2 (0.8)	−0.5, 0.1	0 (−1, 1)	0.4
High creatinine
1.2–1.9 mg/dL	0 (0.0)	24 (68.6)	11 (31.4)	0.3 (0.5)	0.2, 0.5	0 (0, 1)	0.6
2.0–3.4 mg/dL	3 (8.6)	21 (60.0)	11 (31.4)	0.2 (0.6)	0.0, 0.4	0 (0, 1)	−0.1
3.5–4.9 mg/dL	7 (20.0)	18 (51.4)	10 (28.6)	0.1 (0.7)	−0.2, 0.3	0 (0, 1)	−0.1
≥5.0 mg/dL	10 (28.6)	14 (40.0)	11 (31.4)	0.0 (0.8)	−0.2, 0.3	0 (−1, 1)	−0.1
High ESR	2 (5.7)	24 (68.6)	9 (25.7)	0.2 (0.5)	0.0, 0.4	0 (0, 1)	0.2
High CRP	2 (5.7)	20 (57.2)	13 (37.1)	0.3 (0.6)	0.1, 0.5	0 (0, 1)	−1.5
High D-dimer	1 (2.9)	21 (60.0)	13 (37.1)	0.3 (0.5)	0.2, 0.5	0 (0, 1)	0.1
High ferritin	2 (5.7)	25 (71.4)	8 (22.9)	0.2 (0.5)	0.0, 0.4	0 (0, 0)	0.3